Taiwan has enough of the drugs used to treat Mycoplasma pneumoniae, as it increased imports of a brand-name drug last month and expanded domestic production of generic drugs, the Food and Drug Administration (FDA) said yesterday.
As some parts of China are seeing a spike in respiratory illnesses, reportedly caused by multiple pathogens, including the M. pneumoniae bacteria, many Taiwanese media outlets have reported public concerns about children catching M. pneumoniae.
M. pneumoniae is a common bacterial respiratory tract pathogen that causes infections the whole year round in Taiwan, Centers for Disease Control (CDC) Deputy Director-General Philip Lo (羅一鈞) said on Tuesday evening, adding that it mainly spreads from person to person through respiratory droplets.
Photo: CNA
A 2011-2012 survey by the Taiwan Pediatric Infectious Diseases Alliance found that M. pneumoniae was the second-most common pathogen that caused community-acquired pneumonia in children, he said, adding that M. pneumoniae infections are most common in children aged five or older.
The epidemiology of M. pneumoniae has not changed much in 10 years, and most infections are mild, usually resolve on their own and rarely require hospitalization, Lo said.
While historical trends show that M. pneumoniae infections tend to peak every three to seven years, there has not been a significant rise in cases so far this year, he said.
One antibiotic used to treat M. pneumoniae infections in children is azithromycin powder for oral suspension, FDA Deputy Director Cheng Hwei-fang (陳惠芳) said yesterday.
The drug is used to treat bacterial infections of the respiratory tract, skin and soft tissue, as well as otitis media and sexually transmitted diseases, she said, adding that there are two valid drug permits in Taiwan.
An average of 4,680 bottles of azithromycin were used each month last year, but the average monthly usage increased to 8,050 bottles this year, so although 1.3 times more of the drug was imported, supply did not meet demand, she said,
The situation was reported in August, and a large amount of the drug was imported last month, Cheng said, adding that there are about 27,000 bottles in stock, and domestic production of a generic version of the drug has been increased by two to three times.
There are seven valid drug permits in Taiwan for azithromycin oral tablets for adults, and while the average usage is approximately 200,000 tablets per month, there are about 1.3 million tablets in stock — enough to last five to six months — and there are plans to import or manufacture about 2 million tablets next month, so there should be no shortage, she said.
FDA Medicinal Product Division head Yang Bo-wen (楊博文) said in preparation for a likely increase in infections due to Taiwan lifting its COVID-19 restrictions earlier this year and because many respiratory infectious diseases peak in autumn and winter, the FDA on Aug. 2 told drugmakers with permits for antibiotics, drugs for treating respiratory illnesses and gastrointestinal tract infections, antipyretics, and analgesics to ensure a stable supply of the products.
Taiwanese could risk being extradited to China when traveling in countries with close ties to Beijing, Taiwan Association of University Professors deputy chairman Chen Li-fu (陳俐甫) said on Friday. Chen’s comments came after China on Friday last week announced new judicial guidelines targeting Taiwanese independence advocates. Myanmar, Cambodia, Laos and Djibouti are among the countries where Taiwanese could risk being extradited to China, he said. The Mainland Affairs Council (MAC) on Thursday elevated the travel alert for China, Hong Kong and Macau to “orange” after Beijing announced its guidelines to “severely punish Taiwanese independence diehards for splitting the country and inciting secession.” Extradition treaties
Taiwan and Thailand have signed an agreement to promote and protect bilateral investment and trade, the Executive Yuan’s Office of Trade Negotiations (OTN) said on Friday. The agreement on “Promotion and Protection of Investments” was signed by Representative to Thailand Chang Chun-fu (張俊福) and Thailand Trade and Economic Office in Taipei executive director Narong Boonsatheanwong on Thursday, the OTN said in a news release. Thailand has become the fifth trading partner to sign an investment agreement with Taiwan since 2016, following earlier agreements with the Philippines, India, Vietnam and Canada, the OTN said. The deal marks a significant milestone in the development of
The entire Alishan Forest Railway line is to reopen for the first time in 15 years on Saturday, with tickets to go on sale at 2pm today. The historic railway from Chiayi to Alishan (阿里山) is finally set to reopen after the completion of the final No. 42 tunnel, Alishan Forest Railway and Cultural Heritage Office Deputy Director-General Chou Heng-kai (周恆凱) said. It is to run on a new timetable, with four trains daily, he said. The 9am train is to depart from Chiayi Railway Station bound for Shizilu Station (十字路), while the 10am train departing from Chiayi is to go all the
FLU CONTINUES: Hospitals reported 101,091 visits for flu-like illnesses last week, while 68 severe cases and 16 flu-related deaths were also reported, the CDC said The Centers for Disease Control (CDC) yesterday reported 932 hospitalizations due to COVID-19 and 64 related deaths for last week, adding that the number of people who had contracted new SARS-CoV-2 subvariants KP.2 and LB.1 has increased. The number of people hospitalized due to COVID-19 increased from 815 in the previous week to 932 last week, while 90 percent of the 64 deceased were aged 65 or older, CDC physician Lin Yung-ching (林詠青) said. JN.1 was still the dominant variant among local and imported cases in the past four weeks, while KP.2 was the second-most common, Lin said. Cases with the LB.1 subvariant